Basics |
Company: |
Verastem, Inc. |
IPO Date: |
February 1, 2012 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$252.8M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.16 | 3.35%
|
Avg Daily Range (30 D): |
$0.18 | 3.00%
|
Avg Daily Range (90 D): |
$0.20 | 4.35%
|
Institutional Daily Volume |
Avg Daily Volume: |
.16M |
Avg Daily Volume (30 D): |
.81M |
Avg Daily Volume (90 D): |
1.2M |
Trade Size |
Avg Trade Size (Sh.): |
38 |
Avg Trade Size (Sh.) (30 D): |
134 |
Avg Trade Size (Sh.) (90 D): |
144 |
Institutional Trades |
Total Inst.Trades: |
427 |
Avg Inst. Trade: |
$1.93M |
Avg Inst. Trade (30 D): |
$4.38M |
Avg Inst. Trade (90 D): |
$1.85M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.3M |
Avg Closing Trade (30 D): |
$.62M |
Avg Closing Trade (90 D): |
$1.05M |
Avg Closing Volume: |
95.24K |
|
|
|
|
Financials |
|
TTM |
FY 2024 |
TTM |
Basic EPS
|
|
|
$-3.2
|
Diluted EPS
|
|
|
$-3.17
|
Revenue
|
$
|
$
|
$ 10M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$
|
$
|
$ -93.45M
|
Operating Income / Loss
|
$
|
$
|
$ -114.51M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$
|
$
|
$ 16.65M
|
PE Ratio
|
|
|
|
Splits |
Jun 01, 2023:
12:1
|
|